DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Iyengar S, Tay-Teo K, Vogler S. et al.
Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis.
PLoS Med 2016;
13 (05) e1002032-e1002032
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.